Release of phospholipids from erythrocyte membranes by taurocholate is determined by their transbilayer orientation and hydrophobic backbone.
Bile salts mediate a specific release of phosphatidylcholine (PC) from the canalicular membrane into the bile fluid. We utilized human red blood cells (RBC) as a model system to study the release of endogenous phospholipids as well as phospholipid analogues from plasma membranes in the presence of the bile salt taurocholate (TC). Short- and long-chain fluorescent as well as spin-labeled analogues with various headgroups were chosen. RBC were labeled either on the exoplasmic or on the cytoplasmic leaflet with the analogues and incubated with various concentrations of TC. Analogues on the exoplasmic layer could be readily released by TC. Release was most efficient above the critical micellar concentration (CMC) of TC. Release was independent of the headgroup, but depended on the fatty acid chain length of the analogues; i.e., it was lower for long-chain than for short-chain labeled phospholipids. Analogues on the cytoplasmic leaflet were efficiently shielded from TC-mediated release. The preferential release of endogenous PC and sphingomyelin (SM) from the erythrocyte membrane above the CMC supports the conclusion that TC-mediated release of phospholipids occurs preferentially from the exoplasmic leaflet independent of their headgroup. However, the extent of release of endogenous phospholipids was significantly lower in comparison to that of analogues, endorsing the relevance of the hydrophobic backbone for bile salt mediated release of phospholipids. Implications for the mechanism of the release of PC from the canalicular membrane into the bile fluid are discussed.
Wüstner
D
D
Humboldt-Universität zu Berlin, Mathematisch-Naturwissenschaftliche Fakultät I, Institut für Biologie/Biophysik, Invalidenstrasse 43, D-10115 Berlin, Germany.
Pomorski
T
T
Herrmann
A
A
Müller
P
P
D001646:Bile / Q000378:metabolism; D001647:Bile Acids and Salts / Q000494:pharmacology; D001659:Biliary Tract / Q000378:metabolism; D016764:Cell Polarity; D004910:Erythrocyte Membrane / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D005456:Fluorescent Dyes; D006461:Hemolysis; D006801:Humans; D008051:Lipid Bilayers / Q000737:chemistry*; D008823:Micelles; D010743:Phospholipids / Q000737:chemistry / Q000378:metabolism*; D013113:Spin Labels; D013656:Taurocholic Acid / Q000494:pharmacology*
D001647:Bile Acids and Salts; D005456:Fluorescent Dyes; D008051:Lipid Bilayers; D008823:Micelles; D010743:Phospholipids; D013113:Spin Labels; D013656:Taurocholic Acid